Obesity and insulin resistance also decrease NO production via different mechanisms, including blunting of skeletal muscle eNOS expression and activity, consequently impairing the NO-driven endothelium-dependent vasoreactivity [62]. This evidence concerns the gene NOS3 and obesity due to melanocortin 4 receptor deficiency.